Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments.
about
Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspectiveMultimodal treatment approaches for peritoneal carcinosis in colorectal cancerCritical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasisUse of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug.Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of conceptSplenectomy revisited in 2011: Impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer.Analysis of surgery for incurable gastric cancer.Safe temperature range for intraoperative and early postoperative continuous hyperthermic intraperitoneal perfusion in a swine model of experimental distal gastrectomy with Billroth II reconstructionCytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea.Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.Oncology imaging in the abdomen and pelvis: where cancer hides.Selection for hepatic resection: expert consensus conference.The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art.Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence.Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication.Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites?Gold Rods Irradiated with Ultrasound for Combination of Hyperthermia and Cancer Chemotherapy.Toxicity of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients with sarcomatosis/carcinomatosis: early experience and phase 1 results.Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for children, adolescents, and young adults: the first 50 cases.CT-Enteroclysis in the preoperative assessment of the small-bowel involvement in patients with peritoneal carcinomatosis, candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Long noncoding RNA aberrant expression profiles after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of AGC ascertained by microarray analysis.Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study.
P2860
Q26768408-7F25EB96-02B1-485E-889D-16F6EB382234Q26852135-B25EA195-9E72-4259-900D-79E7AAFF7C1FQ33634993-E2E315F2-0A59-4BEF-8164-870D2A9C2F43Q33649940-B5400B37-92E1-4A58-94E0-808BE94646D1Q34129954-5B656BE8-9022-4BA6-BA94-C579FF4DA1F1Q35730208-AB1F63DC-1B5E-45D4-9798-05E4B9D27466Q36097165-66837A6A-79A2-432C-88ED-941278969306Q36269717-48110746-5E75-41AA-961A-74974F5D8FE7Q36383695-96D0BE7E-373E-4EE8-8CE8-8585605880EFQ37071401-B468840E-DE26-4B06-AD51-B4E9125FB0B7Q37339466-962D4864-E9E4-41A2-9CC1-DDB4CAB2F966Q37373079-26F1E72D-95B8-4BF4-8827-4209656F5ECAQ38033094-43AE949B-1F2C-4038-87EB-DDE5D682A033Q38072439-FA4E3CB3-36CD-4DF9-BFA3-D156E3D340A0Q38201470-14EAADCE-4319-4EEC-9D3E-6744CDB0CCABQ38719149-E26C0BC5-A638-4403-B6E8-4F64B14E99A8Q38931710-0753235F-A3C5-45C0-BC0C-5AD63FB5CB99Q39129504-572FE964-8B65-4ACA-A3E5-65E56E007DB2Q42071357-2C5D129E-DFA4-4AF7-BAF0-E66EA5F62B1EQ42181698-44AC9A98-67AE-4EC5-9578-26CF74CF9FE0Q47663602-0C63B2B0-5713-4E0F-B761-5C2F3C899B29Q50431055-2D0BD298-44A6-49D4-8867-359C6DEFACF9Q50441909-12CD0E5D-6012-4380-8CAB-BEAFF93FB00BQ53171509-F4034F2D-EB1A-4A41-AB45-DD409CEEFB6CQ53619335-E7F60E26-A32F-4EE6-8B95-3D700E7775F4Q54466584-F6638CCD-1042-4AC6-A34E-89DB42CF886D
P2860
Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of peritoneal carcin ...... e art and future developments.
@en
Treatment of peritoneal carcin ...... e art and future developments.
@nl
type
label
Treatment of peritoneal carcin ...... e art and future developments.
@en
Treatment of peritoneal carcin ...... e art and future developments.
@nl
prefLabel
Treatment of peritoneal carcin ...... e art and future developments.
@en
Treatment of peritoneal carcin ...... e art and future developments.
@nl
P2093
P1433
P1476
Treatment of peritoneal carcin ...... he art and future developments
@en
P2093
Alfonso De Stefano
Corrado Pedrazzani
Enrico Pinto
Franco Roviello
Stefano Caruso
P304
P356
10.1016/J.SURONC.2010.09.002
P577
2010-12-15T00:00:00Z